Patientdesk.ai raised $1M in a pre-seed round announced on February 24, 2026. Proven in dental scheduling, now expanding to insurance, payments, and care coordination. Already live across 35+ locations with 3 major chains while building.
Proven in dental scheduling, now expanding to insurance, payments, and care coordination. Already live across 35+ locations with 3 major chains while building.
Patientdesk.ai, based in Amsterdam, Netherlands, announced $1M in pre-seed financing on February 24, 2026.
Participants include e2vc, Y Combinator.
the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis.
a TechBio company focused on transforming clinical trials through artificial intelligence.
immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic areas.